Article
Pharmaceutical Executive
SHYFT Analytics announced that Novartis selected its Intelligent Platform for Life Sciences to support the commercialization of therapies in Europe.
Novartis will use the following SHYFT solutions:
Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.